Comparison
21q22 11q22 12 Microdeletion Syndrome C5192593 vs 13q12 3 Microdeletion Syndrome C4750951
Clinical comparison between 21q22 11q22 12 Microdeletion Syndrome and 13q12 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
21q22 11q22 12 Microdeletion Syndrome C5192593
A rare genetic condition involving deletion of a specific region on chromosome 21. It may cause developmental delay, intellectual disability, and distinctive facial features. Management focuses on developmental support and medical monitoring.
13q12 3 Microdeletion Syndrome C4750951
A rare genetic condition where a small piece of chromosome 13 is missing. It can cause various developmental and medical concerns. Care is supportive and tailored to the individual's needs.
6 comparison axes
Onset
21q22 11q22 12 Microdeletion Syndrome C5192593
0-0
13q12 3 Microdeletion Syndrome C4750951
0-null
Onset patterns differ
Severity
21q22 11q22 12 Microdeletion Syndrome C5192593
severe
13q12 3 Microdeletion Syndrome C4750951
moderate
Different severity levels
Chronic
21q22 11q22 12 Microdeletion Syndrome C5192593
Chronic
13q12 3 Microdeletion Syndrome C4750951
Chronic
Differing course
Communicable
21q22 11q22 12 Microdeletion Syndrome C5192593
No
13q12 3 Microdeletion Syndrome C4750951
No
Different transmission
Body System
21q22 11q22 12 Microdeletion Syndrome C5192593
congenital
13q12 3 Microdeletion Syndrome C4750951
congenital
Same/different system
Category
21q22 11q22 12 Microdeletion Syndrome C5192593
rare-disease
13q12 3 Microdeletion Syndrome C4750951
genetic
Different category
Bottom line
21q22-11q22-12-microdeletion-syndrome-C5192593 and 13q12-3-microdeletion-syndrome-C4750951 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 13q12 3 Microdeletion Syndrome C4750951 | Discriminating power |
|---|---|---|---|
| Deleted chromosomal region | Involves a specified region of chromosome 21, reported as 21q22.11-q22.12. | Involves a small missing segment at 13q12.3. | High |
| Developmental concerns | Source links possible developmental delay, intellectual disability, and distinctive facial features. | Source describes variable developmental and medical concerns without a fixed pattern. | Moderate |
| Recorded severity | Supplied severity is severe, but individual expression is not established. | Supplied severity is moderate, but individual expression is not established. | Low |
When to favor each condition
Choose 21q22 11q22 12 Microdeletion Syndrome C5192593 when
A validated genetic report maps the deletion to 21q22.11-q22.12.
The locus is the principal discriminator supplied.
High
Congenital developmental delay with reported intellectual disability needs syndrome labeling.
This fits the limited phenotype boundary only after genetic confirmation.
Moderate
Planning is based solely on the severe severity label.
Severity differs in the source, but it does not prove the diagnosis.
Low
Choose 13q12 3 Microdeletion Syndrome C4750951 when
A validated genetic report maps the deletion to 13q12.3.
The chromosome 13 locus identifies this concept.
High
Findings are variable and no specific facial or cognitive pattern is documented.
The source allows broad developmental and medical concerns.
Moderate
A moderate congenital course is assumed without testing.
The severity axis is supportive only and requires clinician review.
Low
How key tests differ
| Test | 21q22 11q22 12 Microdeletion Syndrome C5192593 | 13q12 3 Microdeletion Syndrome C4750951 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion mapping to 21q22.11-q22.12. | Deletion mapping to 13q12.3. | Locus and breakpoints distinguish them; gene content requires the laboratory report. |
| Karyotype | A small deletion may not be visible. | A small deletion may not be visible. | A normal karyotype excludes neither concept. |
| Developmental assessment | May document delay or intellectual disability. | May document variable developmental concerns. | Results describe function, not the chromosomal diagnosis. |
Prognosis comparison
21q22 11q22 12 Microdeletion Syndrome C5192593
- Outcome
- Long-term outcome is not established; the source only labels severity as severe.
- Factors
- Deleted locus, developmental findings, and associated medical needs.
13q12 3 Microdeletion Syndrome C4750951
- Outcome
- Long-term outcome is not established; the source only labels severity as moderate.
- Factors
- Deleted locus and each person's developmental and medical profile.
Time frame: Congenital and chronic; no reliable timeline is supplied.
Clinician interpretation should guide prognosis because mortality and functional outcomes are unavailable.
Complications comparison
| Complication | Presentation |
|---|---|
| Specific medical complications | Not established in the supplied data. Not established in the supplied data. Do not infer organ complications without clinical records. |
| Developmental support needs | Support and monitoring are emphasized. Supportive, individualized care is emphasized. Needs should follow assessed function rather than the syndrome label alone. |
| Recurrence or transmission | No communicability is indicated. No communicability is indicated. Inheritance and recurrence risk are not established here. |
Patient education highlights
- HighGenetic confirmation
The diagnosis depends on an expert-reviewed genetic report identifying the deleted region.
- MediumVariable presentation
Developmental findings may occur, but exact symptoms and severity vary and are not fully defined here.
- LowCare planning
Care is supportive and individualized; no treatment dose or standard outcome is established.